Sudden cardiac death in chronic kidney disease and dialysis: From descriptive epidemiology to mechanism‐driven prevention
Sudden cardiac death (SCD) is a leading cause of mortality across the chronic kidney disease (CKD) continuum and becomes particularly prominent in dialysis-dependent kidney failure. In hemodialysis, SCD accounts for roughly one quarter to one third of all deaths and up to 60%-75% of cardiovascular mortality, with marked temporal clustering around the long interdialytic interval and the first post-interval session. Traditional views have emphasized descriptive epidemiology and presumed ventricular tachyarrhythmias. More recent device-based studies challenge this paradigm, revealing a heterogeneous arrhythmic spectrum in which bradyarrhythmias, pauses, and conduction system disease are often at least as frequent as sustained ventricular tachycardia or fibrillation. This narrative, non-systematic review synthesizes epidemiologic, mechanistic, and interventional data on SCD in CKD and dialysis, with particular emphasis on insights from implantable loop recorder and implantable cardioverter-defibrillator cohorts and on modifiable dialytic and pharmacologic factors. A framework for prevention is proposed around three interacting domains: the structural myocardial substrate, the electrophysiologic milieu, and dialysis-related triggers. Within this framework, contemporary heart failure and CKD therapies (including sodium-glucose cotransporter 2 inhibitors, angiotensin receptor-neprilysin inhibitors, mineralocorticoid receptor antagonists, and beta-blockers), individualized dialysis prescriptions (targeting potassium, calcium, bicarbonate, ultrafiltration, and scheduling), and selective use of device therapy are considered complementary components of mechanism-driven SCD prevention. Methodological challenges in defining and adjudicating SCD in CKD are discussed, and priorities are outlined for improved phenotyping, continuous rhythm monitoring, and CKD-specific risk stratification, with the overarching aim of moving from descriptive statistics to effective risk modification.
Authors
- Mehmet Kanbay (ORCID: https://orcid.org/0000-0002-1297-0675)
- Francesca Mallamaci (ORCID: https://orcid.org/0000-0003-0322-976X)
- Sophie Liabeuf (ORCID: https://orcid.org/0000-0001-5384-9006)
- Andrzej Więcek (ORCID: https://orcid.org/0000-0002-8625-4188)
- Carmine Zoccali (ORCID: https://orcid.org/0000-0002-6616-1996)
Institutions
- Koç University (TR)
- Medical University of Silesia (PL)
- Centre Hospitalier Universitaire Amiens-Picardie (FR)
- Laboratoire de Glycochimie, des Antimicrobiens et des Agroressources (FR)
- Biogem (IT)
- Società Italiana di Nefrologia (IT)
- Renal Research Institute (US)
- Université de Picardie Jules Verne (FR)
Publication Details
- Journal
- Journal of Internal Medicine
- Published
- 2026-08-21
- DOI
- https://doi.org/10.1111/joim.70127
- Primary Topic
- Dialysis and Renal Disease Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00